TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Develops and manufactures IV solutions, vaccines, and other human medical products.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA

Description

TURK İLAÇ VE SERUM SANAYİ A.Ş. is a pharmaceutical company engaged in the development, manufacturing, and sale of human medical products. The company's core business revolves around the production of IV Parenteral Solutions (serum), operating a high-capacity manufacturing facility that establishes it as a major supplier. In addition to serum, its portfolio includes a variety of other essential pharmaceuticals such as vaccines, ampoules, vials, and tablets. The company has also established a significant presence in biotechnology with the development of an integrated vaccine production facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 09:13
Aversi LLC Yeni iş ilişkisi
Turkish 33.8 KB
2025-11-19 08:47
2025-9 Aylık IMS (IQVIA) resmi verilerinde ürünlerimizin Türkiye Pazarındaki Ku…
Turkish 17.7 KB
2025-11-18 12:36
Emkan Global İle İmzalanan Yetkili Satıcılık Sözleşmesi Hakkında
Turkish 33.8 KB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 1.7 MB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-10-30 16:19
Sorumluluk Beyanı
Turkish 20.4 KB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
Turkish 2.1 MB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
English 10.9 KB
2025-10-30 16:18
Financial Report
Turkish 1.7 MB
2025-10-30 16:18
Financial Report
English 2.5 MB
2025-10-28 17:23
Sürdürülebilirlik Komitesi Üye Seçimi
Turkish 17.4 KB
2025-10-07 13:01
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-10-07 12:49
DMO İhale Sonucu Hakkında
English 42.6 KB
2025-09-29 14:13
Finansman Bonosu İtfası Hakkında
English 15.2 KB
2025-09-29 07:01
Satışın Tamamlanması Hakkında
English 18.2 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.